Luis Paz-Ares, Mikhail Dvorkin, Yuanbin Chen, Bernd Lamprecht, et al.,
"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial"
, in The Lancet, Vol. 394, Nummer 10212, Seite(n) 1929-1939, 11-2019, ISSN: 1474-547X
Original Titel:
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Forschungs-